2v2w: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2v2w.jpg|left|200px]] | [[Image:2v2w.jpg|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2v2w", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_2v2w| PDB=2v2w | SCENE= }} | |||
}} | |||
'''T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT''' | '''T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT''' | ||
Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
2V2W is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry | 2V2W is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=2bsu 2bsu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2V2W OCA]. | ||
==Reference== | ==Reference== | ||
Line 35: | Line 32: | ||
[[Category: Merwe, P A.Van Der.]] | [[Category: Merwe, P A.Van Der.]] | ||
[[Category: Stewart-Jones, G.]] | [[Category: Stewart-Jones, G.]] | ||
[[Category: | [[Category: Aid]] | ||
[[Category: | [[Category: Disease mutation]] | ||
[[Category: Glycoprotein]] | |||
[[Category: Hiv]] | |||
[[Category: | [[Category: Hla-a2]] | ||
[[Category: | [[Category: Host-virus interaction]] | ||
[[Category: | [[Category: Immune response]] | ||
[[Category: | [[Category: Immune system]] | ||
[[Category: | [[Category: Immunoglobulin domain]] | ||
[[Category: | [[Category: Membrane]] | ||
[[Category: | [[Category: Mhc]] | ||
[[Category: | [[Category: Mhc i]] | ||
[[Category: | [[Category: Polymorphism]] | ||
[[Category: | [[Category: Pyrrolidone carboxylic acid]] | ||
[[Category: | [[Category: Tcr]] | ||
[[Category: | [[Category: Transmembrane]] | ||
[[Category: | [[Category: Ubl conjugation]] | ||
[[Category: | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 18:07:29 2008'' | ||
[[Category: | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |
Revision as of 18:07, 4 May 2008
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
OverviewOverview
All thymically selected T cells are inherently cross-reactive, yet many data indicate a fine specificity in antigen recognition, which enables virus escape from immune control by mutation in infections such as the human immunodeficiency virus (HIV). To address this paradox, we analyzed the fine specificity of T cells recognizing a human histocompatibility leukocyte antigen (HLA)-A2-restricted, strongly immunodominant, HIV gag epitope (SLFNTVATL). The majority of 171 variant peptides tested bound HLA-A2, but only one third were recognized. Surprisingly, one recognized variant (SLYNTVATL) showed marked differences in structure when bound to HLA-A2. T cell receptor (TCR) recognition of variants of these two peptides implied that they adopted the same conformation in the TCR-peptide-major histocompatibility complex (MHC) complex. However, the on-rate kinetics of TCR binding were identical, implying that conformational changes at the TCR-peptide-MHC binding interface occur after an initial permissive antigen contact. These findings have implications for the rational design of vaccines targeting viruses with unstable genomes.
About this StructureAbout this Structure
2V2W is a Protein complex structure of sequences from Homo sapiens. This structure supersedes the now removed PDB entry 2bsu. Full crystallographic information is available from OCA.
ReferenceReference
T cell cross-reactivity and conformational changes during TCR engagement., Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, Dorrell L, Douek DC, van der Merwe PA, Jones EY, McMichael AJ, J Exp Med. 2004 Dec 6;200(11):1455-66. PMID:15583017 Page seeded by OCA on Sun May 4 18:07:29 2008
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Pages with broken file links
- Homo sapiens
- Protein complex
- Dong, T.
- Dorrell, L.
- Douek, D C.
- Gleria, K Di.
- Harlos, K.
- Jones, E Y.
- Lee, J K.
- Mcmichael, A J.
- Merwe, P A.Van Der.
- Stewart-Jones, G.
- Aid
- Disease mutation
- Glycoprotein
- Hiv
- Hla-a2
- Host-virus interaction
- Immune response
- Immune system
- Immunoglobulin domain
- Membrane
- Mhc
- Mhc i
- Polymorphism
- Pyrrolidone carboxylic acid
- Tcr
- Transmembrane
- Ubl conjugation